The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Ocular Drug Delivery
Open accessAbstract
Ocular drug delivery has been a major challenge to pharmacologists and drug delivery scientists due to its unique anatomy and physiology. Static barriers (different layers of cornea, sclera, and retina including blood aqueous and blood-retinal barriers), dynamic barriers (choroidal and conjunctival blood flow, lymphatic clearance, and tear dilution), and efflux pumps in conjunction pose a significant challenge for delivery of a drug alone or in a dosage form, especially to the posterior segment. Identification of influx transporters on various ocular tissues and designing a transporter-targeted delivery of a parent drug has gathered momentum in recent years. Parallelly, colloidal dosage forms such as nanoparticles, nanomicelles, liposomes, and microemulsions have been widely explored to overcome various static and dynamic barriers. Novel drug delivery strategies such as bioadhesive gels and fibrin sealant-based approaches were developed to sustain drug levels at the target site. Designing noninvasive sustained drug delivery systems and exploring the feasibility of topical application to deliver drugs to the posterior segment may drastically improve drug delivery in the years to come. Current developments in the field of ophthalmic drug delivery promise a significant improvement in overcoming the challenges posed by various anterior and posterior segment diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This method avoids complications of first-pass metabolism and has the advantage of easy administration, sometimes by the patients themselves. However, barriers, such as the pre-corneal tear film, the structure of the cornea, limited volume, lacrimal drainage system, reflex tearing, and aqueous outflow of the eye, reduce the bioavailability of the product to around 5% or less.35,118,119”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [119]
In the citing paper
“Most gene therapy viral vectors given intravitreally, fail to adequately transduce photoreceptors and RPE, due to the inner limiting membrane that divides the vitreous from the retina.1,15,119,127”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [119]
In the citing paper
“Despite these advantages, intravitreal injections also carry risks of adverse reactions, including inflammation, endophthalmitis, increased intraocular pressure, retinal detachment, hemorrhage, and cataracts, and due to the repeated use of these injections in various treatments, patient compliance can become an issue.119,127,129”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Cyclodextrins and their uses: a review
Del Valle, E. M. M. (2004) · Process Biochemistry · doi:10.1016/s0032-9592(03)00258-9 · Cited by 3,375
Cyclodextrins and their pharmaceutical applications
Loftsson, Þ., & Duchêne, D. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,766
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D.-M., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,681
Tomalia, D. A. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.01.007 · Cited by 1,115
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye
Prausnitz, M. R., & Noonan, J. S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802594 · Cited by 630
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S., & Mitra, A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 600
Self-citationSieving, P. A., Caruso, R. C., Tao, W., Coleman, H. R., Thompson, D. J. S., Fullmer, K. R., & Bush, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600236103 · Cited by 591
Topical Ocular Drug Delivery: Recent Developments and Future Challenges
Lee, V. H. L., & Robinson, J. R. (1986) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1986.2.67 · Cited by 504
Viral Vectors for Gene Transfer
Walther, W., & Stein, U. (2000) · Drugs · doi:10.2165/00003495-200060020-00002 · Cited by 452
Vesicular systems in ocular drug delivery: an overview
Kaur, I. P., Garg, A. B., Singla, A. K., & Aggarwal, D. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.016 · Cited by 450
Current and future ophthalmic drug delivery systems
del Amo, E. M., & Urtti, A. O. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.002 · Cited by 424
Vandamme, T. F., & Brobeck, L. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.015 · Cited by 402
Topical and systemic drug delivery to the posterior segments
HUGHES, P., OLEJNIK, O., Chang-Lin, J.-E., & WILSON, C. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.004 · Cited by 400
Inner limiting membrane barriers to aav-mediated retinal transduction from the vitreous
Dalkara, D., Kolstad, K. D., Caporale, N., Visel, M., Klimczak, R. R., Schaffer, D. V., & Flannery, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.181 · Cited by 357
Mannermaa, E., Vellonen, K., & Urtti, A. O. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.024 · Cited by 356
Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies
Hathout, R. M., Mansour, S., Mortada, N. D., & Guinedi, A. S. (2007) · AAPS PharmSciTech · doi:10.1208/pt0801001 · Cited by 346
Ghate, D. A., & Edelhauser, H. F. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.275 · Cited by 336
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation
Shaunak, S., Thomas, S., Gianasi, E., Godwin, A., Jones, E., Teo, I. A., Mireskandari, K., Luthert, P. J., Duncan, R., Patterson, S., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt995 · Cited by 331
Suprachoroidal drug delivery to the back of the eye using hollow microneedles
Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0271-y · Cited by 330
Role of Mucins in the Function of the Corneal and Conjunctival Epithelia
Gipson, I. K., & Argüeso, P. (2003) · International review of cytology · doi:10.1016/s0074-7696(03)31001-0 · Cited by 323
Juillerat‐Jeanneret, L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.09.005 · Cited by 318
Ocular novel drug delivery: impacts of membranes and barriers
Barar, J., Javadzadeh, A., & Omidi, Y. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.5.567 · Cited by 309
Ophthalmic Drug Delivery through Contact Lenses
Gulsen, D., & Chauhan, A. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0959 · Cited by 305
Biodegradable Implants for Sustained Drug Release in the Eye
Lee, S. S., Hughes, P. M., Ross, A. D., & Robinson, M. R. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0159-x · Cited by 288
Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
Ahmed, I., & Patton, T. F. (1985) · PubMed · Cited by 287
Interaction Between Chemicals and Melanin
LARSSON, B. S. (1993) · Pigment Cell Research · doi:10.1111/j.1600-0749.1993.tb00591.x · Cited by 287
Coated Microneedles for Drug Delivery to the Eye
Jiang, J., Gill, H. S., Ghate, D. A., McCarey, B. E., Patel, S. R., Edelhauser, H. F., & Prausnitz, M. R. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0066 · Cited by 286
Transscleral drug delivery for posterior segment disease
Geroski, D. H., & Edelhauser, H. F. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00193-4 · Cited by 282
Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle
Gulsen, D., & Chauhan, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.033 · Cited by 277
Talcott, K. E., Ratnam, K., Sundquist, S. M., Lucero, A. S., Lujan, B. J., Tao, W., Porco, T. C., Roorda, A., & Duncan, J. L. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6479 · Cited by 276
Ocular drug delivery by liposome–chitosan nanoparticle complexes (LCS-NP)
Diebold, Y., Jarrı́n, M., Sáez, V., Carvalho, E. L. S., Orea, M. J., Calonge, M., Seijo, B., & Alonso, M. J. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.028 · Cited by 273
Permeability of Retinal Pigment Epithelium: Effects of Permeant Molecular Weight and Lipophilicity
Pitka¨nen, L., Ranta, V.-P., Moilanen, H., & Urtti, A. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1051 · Cited by 261
Kompella, U., Bandi, N., & Ayalasomayajula, S. (2003) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.02-0791 · Cited by 259
Periocular routes for retinal drug delivery
Raghava, S., Hammond, M., & Kompella, U. B. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.99 · Cited by 257
Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery
Li, N., Zhuang, C.-Y., Wang, M., Sun, X., Nie, S., & Pan, W. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.020 · Cited by 248
Intraocular implants for extended drug delivery: Therapeutic applications
Bourges, J., Bloquel, C., Thomas, A., Froussart, F., Bochot, A., Azan, F., Gurny, R., BenEzra, D., & Béhar‐Cohen, F. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.026 · Cited by 239
Drug delivery to the retina: challenges and opportunities
Duvvuri, S., Majumdar, S., & Mitra, A. K. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.1.45 · Cited by 238
Self-citationSammalkorpi, M., Karttunen, M., & Haataja, M. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp901228v · Cited by 235
Kim, J. H., Kim, J. H., Kim, K., Kim, M. H., & Yu, Y. S. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/50/505101 · Cited by 228
Amrite, A. C., & Kompella, U. B. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.57.12.0005 · Cited by 213
Singh, S. R., GROSSNIKLAUS, H. E., Kang, S. J., Edelhauser, H. F., Ambati, B. K., & Kompella, U. B. (2009) · Gene Therapy · doi:10.1038/gt.2008.185 · Cited by 211
Intrascleral Drug Delivery to the Eye Using Hollow Microneedles
Jiang, J., Moore, J. S., Edelhauser, H. F., & Prausnitz, M. R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9756-3 · Cited by 209
Weber, M., Rabinowitz, J., Provost, N., Conrath, H., Folliot, S., Briot, D., Chérel, Y., Chenuaud, P., Samulski, J., Moullier, P., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00098-4 · Cited by 203
Acyclovir-containing liposomes for potential ocular delivery
Law, S. L., Huang, K.-J., & Chiang, C. ‐. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00192-3 · Cited by 202
Bainbridge, J., Stephens, C., Parsley, K., Demaison, C., Halfyard, A., Thrasher, A., & Ali, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301574 · Cited by 197
Gan, L., Han, S., Shen, J., Zhu, J., Zhu, C., Zhang, X., & Gan, Y. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.015 · Cited by 197
Acetazolamide: future perspective in topical glaucoma therapeutics
Kaur, I. P., Smitha, R., Aggarwal, D., & Kapil, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00438-6 · Cited by 192
AAV hybrid serotypes: improved vectors for gene delivery
Choi, V., McCarty, D., & Samulski, R. (2005) · Current Gene Therapy · doi:10.2174/1566523054064968 · Cited by 191
Vitreous: A Barrier to Nonviral Ocular Gene Therapy
Peeters, L., Sanders, N. N., Braeckmans, K., Boussery, K., Van de Voorde, J., De Smedt, S. C., & Demeester, J. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0165 · Cited by 189 · cited 2×
“Polystyrene nanospheres do not diffuse freely into the vitreous due to their adherence to collagen fibrillar structures (39).”
BackgroundYang, H., Morris, J. J., & Lopina, S. T. (2004) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2003.12.023 · Cited by 185
Transport processes across the rabbit corneal epithelium: a review
Klyce, S. D., & Crosson, C. E. (1985) · Current Eye Research · doi:10.3109/02713688509025145 · Cited by 185
High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection
Weijtens, O., Feron, E. J., Schoemaker, R. C., Cohen, A. F., Lentjes, E. G. W. M., Romijn, F. P. H. T. M., & van Meurs, J. C. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00129-4 · Cited by 184
Huang, X. B., & Lowe, T. L. (2005) · Biomacromolecules · doi:10.1021/bm050116t · Cited by 181
Binding of Drugs to Eye Melanin Is Not Predictive of Ocular Toxicity
Leblanc, B., Jezequel, S. G., Davies, T., Hanton, G. C., & Taradach, C. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1998.1243 · Cited by 179
Kim, H., Robinson, S. B., & Csaky, K. G. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9745-6 · Cited by 174
Transport Barriers in Transscleral Drug Delivery for Retinal Diseases
Kim, S. H., Lutz, R. J., Wang, N. S., & Robinson, M. R. (2007) · Ophthalmic Research · doi:10.1159/000108117 · Cited by 173
Liposomes in topical drug delivery.
Schaeffer, H. E., & Krohn, D. L. (1982) · PubMed · Cited by 170
Yiyun, C., & Xu, T. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.06.010 · Cited by 168
Gupta, A. K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00508-1 · Cited by 160
Dispersion of DMPC Liposomes in Contact Lenses for Ophthalmic Drug Delivery
Gulsen, D., Li, C., & Chauhan, A. (2005) · Current Eye Research · doi:10.1080/02713680500346633 · Cited by 159
Jaffe, G. J., McCallum, R. M., Branchaud, B., Skalak, C., Butuner, Z., & Ashton, P. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.03.013 · Cited by 158
Zhang, T., Xiang, C. D., Gale, D. C., Carreiro, S. T., Wu, E. Y., & Zhang, E. Y. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021121 · Cited by 156
Colloidal Carriers for Ophthalmic Drug Delivery
Mainardes, R. M., Urban, M. C. C., Cinto, P. O., Khalil, N. M., Chaud, M. V., Evangelista, R. C., & Gremião, M. P. D. (2005) · Current Drug Targets · doi:10.2174/1389450053765914 · Cited by 155
Gene delivery to the eye using adeno-associated viral vectors
Martin, K. R. G., Klein, R. L., & Quigley, H. A. (2002) · Methods · doi:10.1016/s1046-2023(02)00232-3 · Cited by 149
Distribution of peptide transporter PEPT2 mRNA in the rat nervous system
Berger, U. V., & Hediger, M. A. (1999) · Anatomy and Embryology · doi:10.1007/s004290050242 · Cited by 146
Gene therapy progress and prospects: the eye
Bainbridge, J. W., Tan, M. H., & Ali, R. R. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302812 · Cited by 144
Chévez-Barrios, P., Chintagumpala, M., Mieler, W., Paysse, E., Boniuk, M., Kozinetz, C., Hurwitz, M. Y., & Hurwitz, R. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.1883 · Cited by 143
Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers
Lopez, A. I., Reins, R. Y., McDermott, A. M., Trautner, B. W., & Cai, C. (2009) · Molecular BioSystems · doi:10.1039/b904746h · Cited by 142
Ayalasomayajula, S. P., & Kompella, U. B. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.019 · Cited by 141
Choonara, Y. E., Pillay, V., Danckwerts, M. P., Carmichael, T. R., & du Toit, L. C. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21987 · Cited by 139
Cationic Vectors in Ocular Drug Delivery
Rabinovich‐Guilatt, L., Couvreur, P., Lambert, G., & Dubernet, C. (2004) · Journal of drug targeting · doi:10.1080/10611860400015910 · Cited by 139
Vitreous Is a Barrier in Nonviral Gene Transfer by Cationic Lipids and Polymers
Pitkänen, L., Ruponen, M., Nieminen, J., & Urtti, A. (2003) · Pharmaceutical Research · doi:10.1023/a:1023238530504 · Cited by 134
Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery
Nagarsenker, M. S., Londhe, V. Y., & Nadkarni, G. D. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00265-3 · Cited by 134
Aburahma, M. H., & Mahmoud, A. A. K. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9701-3 · Cited by 133
P-glycoprotein expression in human retinal pigment epithelium.
Kennedy, B. G., & Mangini, N. J. (2002) · PubMed · Cited by 130
PLGA–PEG–PLGA hydrogel for ocular drug delivery of dexamethasone acetate
Gao, Y., Sun, Y., Ren, F., & Gao, S. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639041003680826 · Cited by 130
Dey, S., Patel, J., Anand, B. S., Jain-Vakkalagadda, B., Kaliki, P., Pal, D., Ganapathy, V., & Mitra, A. K. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1142 · Cited by 128
Self-citationZhang, J., & Wang, S. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.001 · Cited by 128
Amrite, A. C., Edelhauser, H. F., Singh, S. R., & Kompella, U. B. (2008) · PubMed Central · Cited by 125
Liaw, J., Chang, S.-F., & Hsiao, F.-C. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301485 · Cited by 125
Sigurðsson, H. H., Konrádsdóttir, F., Loftsson, Þ., & Stefánsson, E. (2007) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2007.00885.x · Cited by 122
Bemelmans, A., Kostic, C., Crippa, S. V., Hauswirth, W. W., Lem, J., Munier, F. L., Seeliger, M. W., Wenzel, A., & Arsenijévic, Y. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030347 · Cited by 121
Dexamethasone transport and ocular delivery from poly(hydroxyethyl methacrylate) gels
KIM, J., & Chauhan, A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.049 · Cited by 120
Distribution of Brimonidine into Anterior and Posterior Tissues of Monkey, Rabbit, and Rat Eyes
Acheampong, A., Shackleton, M., John, B. A., Burke, J. E., Wheeler, L. A., & Tang-Liu, D. D.-S. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.4.421 · Cited by 120
van Adel, B. A., Kostic, C., Déglon, N., Ball, A. K., & Arsenijévic, Y. (2003) · Human Gene Therapy · doi:10.1089/104303403321070801 · Cited by 114
Mannis, M. J. (1993) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)71425-4 · Cited by 110
Loftsson, Þ., Hreinsdóttir, D., & Stefánsson, E. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.5.0002 · Cited by 110
Ocular gene delivery using lentiviral vectors
Balaggan, K. S., & Ali, R. R. (2011) · Gene Therapy · doi:10.1038/gt.2011.153 · Cited by 108
Lotery, A. J., Yang, G. S., Mullins, R. F., Russell, S. R., Schmidt, M., Stone, E. M., Lindbloom, J. D., Chiorini, J. A., Kotin, R. M., & Davidson, B. L. (2003) · Human Gene Therapy · doi:10.1089/104303403322542301 · Cited by 107
Nanoparticle applications in ocular gene therapy
Cai, X., Conley, S. M., & Naash, M. I. (2007) · Vision Research · doi:10.1016/j.visres.2007.07.012 · Cited by 107
Cheruvu, N. P. S., & Kompella, U. B. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0404 · Cited by 107
Preparation and ocular pharmacokinetics of ganciclovir liposomes
Shen, Y., & Tu, J. (2007) · The AAPS Journal · doi:10.1208/aapsj0903044 · Cited by 106
Anand, B. S., & Mitra, A. K. (2002) · Pharmaceutical Research · doi:10.1023/a:1019806411610 · Cited by 105
Self-citationMolecular Design for Enhancement of Ocular Penetration
Shirasaki, Y. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21200 · Cited by 101
Natarajan, J. V., Chattopadhyay, S., Ang, M., Darwitan, A., Foo, S. E. M., Zhen, M., Koo, M., Wong, T. T. L., & Venkatraman, S. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024513 · Cited by 100
Koevary, S. B. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489488 · Cited by 99
Zhang, R., He, R., Jiang, Q., Guo, J., Xue, K., & Yuan, Y.-F. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4373 · Cited by 98
Derwent, J. J. K., & Mieler, W. F. (2008) · PubMed · Cited by 97
Misra, G. P., Singh, R. S., Alemán, T. S., Jacobson, S. G., Gardner, T. W., & Lowe, T. L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.025 · Cited by 96
Effect of Eye Pigmentation on Transscleral Drug Delivery
Cheruvu, N. P. S., Amrite, A. C., & Kompella, U. B. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0214 · Cited by 95
Vitreous Penetration of Orally Administered Valacyclovir
Huynh, T. H., Johnson, M. W., Comer, G. M., & Fish, D. N. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.11.016 · Cited by 94
A Nonionic Surfactant/Chitosan Micelle System in an Innovative Eye Drop Formulation
Pepić, I., Hafner, A., Lovrić, J., Pirkić, B., & Filipović‐Grčić, J. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22137 · Cited by 94
Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives
Rolling, F. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302366 · Cited by 93
Zhang, L. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s6428 · Cited by 93
Marano, R. J., Wimmer, N., Kearns, P. S., Thomas, B. G., Tóth, I., Brankov, M., & Rakoczy, P. E. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2004.06.023 · Cited by 92
Subconjunctival Carboplatin in Fibrin Sealant in the Treatment of Transgenic Murine Retinoblastoma
VANQUILL, K., Dioguardi, P. K., TONG, C., Gilbert, J. A., AABERGJR, T., Grossniklaus, H. E., EDELHAUSER, H., & OBRIEN, J. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.11.060 · Cited by 91
Kinetics of macromolecules injected into the subretinal space
Marmor, M. F., Negi, A., & Maurice, D. M. (1985) · Experimental Eye Research · doi:10.1016/0014-4835(85)90138-1 · Cited by 90
Ocular Drug Delivery; Impact of in vitro Cell Culture Models.
Barar, J., Asadi, M., Mortazavi‐Tabatabaei, S. A., & Omidi, Y. (2009) · PubMed Central · Cited by 90
Durairaj, C., Kadam, R. S., Chandler, J., Hutcherson, S. L., & Kompella, U. B. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5388 · Cited by 86
Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors
Balaggan, K. S., Binley, K. E., Esapa, M., Iqball, S., Askham, Z., Kan, O., Tschernutter, M., Bainbridge, J. W., Naylor, S., & Ali, R. R. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.845 · Cited by 86
Oral omega-6 essential fatty acid treatment in contact lens associated dry eye
Kokke, K. H., Morris, J. A., & Lawrenson, J. G. (2008) · Contact Lens and Anterior Eye · doi:10.1016/j.clae.2007.12.001 · Cited by 86
Dey, S., Gunda, S., & Mitra, A. K. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069583 · Cited by 85
Self-citationMicellar solutions of triblock copolymer surfactants with pilocarpine
Pepić, I., Jalšenjak, N., & Jalšenjak, I. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.11.032 · Cited by 84
Aukunuru, J., Sunkara, G., Bandi, N., Thoreson, W. B., & Kompella, U. B. (2001) · Pharmaceutical Research · doi:10.1023/a:1011060705599 · Cited by 82
Preparation and characterization of puerarin–dendrimer complexes as an ocular drug delivery system
Yao, W., Sun, K., Mu, H., Liang, N., Liu, Y., Chen, Y., Liang, R., & Wang, A. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639041003610799 · Cited by 82
Tirucherai, G., & Mitra, A. K. (2003) · AAPS PharmSciTech · doi:10.1208/pt040345 · Cited by 81
Self-citationTakahashi, K. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.27 · Cited by 80
Charged nanoparticles delivery to the eye using hydrogel iontophoresis
Eljarrat‐Binstock, E., Orucov, F., Aldouby, Y., Frucht‐Pery, J., & Domb, A. J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.016 · Cited by 78
Usayapant, A., Karara, A. H., & Narurkar, M. M. (1991) · Pharmaceutical Research · doi:10.1023/a:1015838215268 · Cited by 77
Kompella, U. B., Sundaram, S., Raghava, S., & Escobar, E. R. (2006) · PubMed · Cited by 77
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate
Dalpiaz, A., Filosa, R., Caprariis, P. D., Conte, G. M., Bortolotti, F., Biondi, C., Scatturin, A., Prasad, P. D., & Pavan, B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.051 · Cited by 76
Kim, S. H., Csaky, K. G., Wang, N. S., & Lutz, R. J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9408-z · Cited by 74
A primary culture model of rabbit conjunctival epithelial cells exhibiting tight barrier properties
Saha, P., Kim, K.-J., & Lee, V. H. L. (1996) · Current Eye Research · doi:10.3109/02713689608995151 · Cited by 73
Cappello, B., Carmignani, C., Iervolino, M., Rotonda, M. I. L., & Saettone, M. F. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00648-7 · Cited by 72
Yang, J. J., Kim, K.-J., & Lee, V. H. L. (2000) · Pharmaceutical Research · doi:10.1023/a:1007508714259 · Cited by 70
Kawazu, K., Yamada, K., Nakamura, M., & Ota, A. (1999) · PubMed · Cited by 70
Anand, B. S., Patel, J., & Mitra, A. K. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044313 · Cited by 70
Self-citationXiang, C. D., Batugo, M. R., Gale, D. C., Zhang, T., Ye, J., Li, C., Zhou, S., Wu, E. Y., & Zhang, E. Y. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.026286 · Cited by 70
Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells.
Saha, P., Yang, J. J., & Lee, V. H. L. (1998) · PubMed · Cited by 68
Majumdar, S., Nashed, Y. E., Patel, K., Jain, R., Itahashi, M., Neumann, D. M., Hill, J. M., & Mitra, A. K. (2005) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2005.21.463 · Cited by 68
Self-citationP-Glycoprotein expression in human retinal pigment epithelium cell lines
Constable, P. A., Lawrenson, J. G., Dolman, D. E. M., Arden, G. B., & Abbott, N. J. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.10.029 · Cited by 68
Freeze-fracture quantitative comparison of rabbit corneal epithelial and endothelial membranes
McLaughlin, B. J., Caldwell, R. B., Sasaki, Y., & Wood, T. O. (1985) · Current Eye Research · doi:10.3109/02713689509000002 · Cited by 68
Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits
Loftsson, Þ., Friðriksdóttir, H., Stefánsson, E., Thórisdóttir, S., Gudmundsson, Ó. S., & Sigthórsson, T. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03835.x · Cited by 65
Lönngren, U., Näpänkangas, U., Lafuente, M. P., Mayor, S., Lindqvist, N., Vidal‐Sanz, M., & Hallböök, F. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.09.005 · Cited by 65
Current prodrug strategies via membrane transporters/receptors
Anand, B. S., Dey, S., & Mitra, A. K. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.6.607 · Cited by 65
Self-citationIntravitreal Pharmacokinetics of Plain and Liposome-Entrapped Fluconazole in Rabbit Eyes
Gupta, S. K., Velpandian, T., Dhingra, N., & Jaiswal, J. K. (2000) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2000.16.511 · Cited by 64
Goldblum, D., Rohrer, K., Frueh, B. E., Theurillat, R., Thormann, W., & Zimmerli, S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3719-3723.2002 · Cited by 63
Effluxing ABC transporters in human corneal epithelium
Vellonen, K., Mannermaa, E., Turner, H. C., Häkli, M., Wolosin, J. M., Tervo, T., Honkakoski, P., & Urtti, A. O. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21878 · Cited by 62
Jansen, T., Xhonneux, B., Mesens, J., & Borgers, M. J. (1990) · PubMed · Cited by 60
Reer, O., Bock, T. K., & Müller, B. W. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830928 · Cited by 60
Furrer, E., Berdugo, M., Stella, C., Béhar‐Cohen, F., Gurny, R., Feige, U., Lichtlen, P., & Urech, D. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2370 · Cited by 59
Santulli, R. J., Kinney, W. A., Ghosh, S., DeCorte, B. L., Liu, L., Tuman, R. W., Zhao, Z., Huebert, N. D., Bursell, S. E., Clermont, A. C., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131656 · Cited by 59
Karla, P. K., Pal, D., Quinn, T., & Mitra, A. K. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.031 · Cited by 59
Self-citationSubconjunctival Topotecan in Fibrin Sealant in the Treatment of Transgenic Murine Retinoblastoma
Tsui, J. Y., Dalgard, C. L., Quill, K. R. V., Lee, L., Grossniklaus, H. E., Edelhauser, H. F., & O’Brien, J. M. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0653 · Cited by 58
Stable RAAV-Mediated Transduction of Rod and Cone Photoreceptors in the Canine Retina
Bainbridge, J. W. B., Mistry, A., Schlichtenbrede, F. C., Smith, A., Broderick, C., De Alwis, M., Georgiadis, A., Taylor, P. M., Squires, M., Sethi, C., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301990 · Cited by 58
Karla, P. K., Earla, R., Boddu, S. H., Johnston, T. P., Pal, D., & Mitra, A. K. (2009) · Current Eye Research · doi:10.1080/02713680802518251 · Cited by 58
Self-citationJain-Vakkalagadda, B., Pal, D., Gunda, S., Nashed, Y. E., Ganapathy, V., & Mitra, A. K. (2004) · Molecular Pharmaceutics · doi:10.1021/mp0499499 · Cited by 57
Self-citationUltrasound-Enhanced Transcorneal Drug Delivery
Zderic, V., Clark, J. I., Martin, R. W., & Vaezy, S. (2004) · Cornea · doi:10.1097/01.ico.0000134189.33549.cc · Cited by 57
Pitkänen, L., Ranta, V., Moilanen, H., & Urtti, A. O. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9342-0 · Cited by 56
Garrett, Q., Xu, S., Simmons, P. A., Vehige, J. G., Flanagan, J., & Willcox, M. D. P. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1528 · Cited by 55
Doxycycline-Mediated Inhibition of Choroidal Neovascularization
Samtani, S., Amaral, J., Campos, M. M., Fariss, R. N., & Becerra, S. P. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3174 · Cited by 55
Transscleral Diffusion of Carboplatin
Simpson, A. E. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.8.1069 · Cited by 55
Jain-Vakkalagadda, B., Dey, S., Pal, D., & Mitra, A. K. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0907 · Cited by 54
Self-citationKatragadda, S., Talluri, R. S., & Mitra, A. K. (2006) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.22.110 · Cited by 54
Self-citationTrittibach, P. C., Barker, S. E., Broderick, C. A., Natkunarajah, M., Durán, Y., Robbie, S. J., Bainbridge, J. W., Smith, A. J., Sarra, G., Dick, A. D., et al. (2008) · Gene Therapy · doi:10.1038/gt.2008.109 · Cited by 54
Gunda, S., Hariharan, S., & Mitra, A. K. (2006) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.22.465 · Cited by 52
Self-citationTreatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir.
Ausayakhun, S., Yuvaves, P., Ngamtiphakom, S., & Prasitsilp, J. (2005) · PubMed · Cited by 52
Janoria, K. G., Boddu, S. H. S., Wang, Z., Paturi, D., Samanta, S., Pal, D., & Mitra, A. K. (2009) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2008.0040 · Cited by 51
Self-citationCheng, L., Hostetler, K. Y., Chaidhawangul, S., Gardner, M. F., Beadle, J. R., Keefe, K., Bergeron-Lynn, G., SEVERSON, G. M., Soules, K. A., Mueller, A. J., et al. (2000) · PubMed · Cited by 49
Talluri, R. S., Samanta, S., Gaudana, R., & Mitra, A. K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.024 · Cited by 49
Self-citationBary, A. R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00108-9 · Cited by 49
Poeschla, E. M., Barraza, R., Rasmussen, C., Loewen, N., Cameron, J. D., Gabelt, B. T., Teo, W., & Kaufman, P. L. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.086 · Cited by 48
Mitra, A. K., Anand, B. S., & Duvvuri, S. (2005) · Advances in organ biology · doi:10.1016/s1569-2590(05)10012-3 · Cited by 47
Self-citationLoewen, N. A., Bahler, C. K., Teo, W., Whitwam, T., Peretz, M., Xu, R., Fautsch, M. P., Johnson, D. H., & Poeschla, E. M. (2002) · PubMed · Cited by 47
Tirucherai, G., Dias, C. S., & Mitra, A. K. (2002) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076802321021081 · Cited by 47
Self-citationHolló, G., Whitson, J. T., Faulkner, R. D., McCue, B. A., Curtis, M., Wieland, H., Chastain, J. E., Sanders, M., DeSantis, L. M., Przydryga, J., et al. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0945 · Cited by 47
Expression of Multidrug Resistance Associated Protein 5 (MRP5) on Cornea and Its Role in Drug Efflux
Karla, P. K., Quinn, T., Herndon, B., Thomas, P., Pal, D., & Mitra, A. K. (2009) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2008.0084 · Cited by 47
Self-citationMajumdar, S., Hingorani, T., Srirangam, R., Gadepalli, R. S., Rimoldi, J. M., & Repka, M. A. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9730-0 · Cited by 46
Hosseini, K., Matsushima, D., Johnson, J. A., Widera, G., Nyam, K., Kim, L., Xu, Y., Yao, Y., & Cormier, M. (2008) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2007.0117 · Cited by 46
Boddu, S. H. S., Jwala, J., Chowdhury, M. R., & Mitra, A. K. (2010) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2010.0048 · Cited by 46
Self-citationOcular Pharmacokinetics of Cephalosporins using Microdialysis
Macha, S., & Mitra, A. K. (2001) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076801753266866 · Cited by 46
Self-citationLoewen, N. A., Fautsch, M. P., Teo, W., Bahler, C. K., Johnson, D. H., & Poeschla, E. M. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0366 · Cited by 46
Transcorneal Iontophoresis for Delivery of Ciprofloxacin Hydrochloride
Vaka, S. R. K., Sammeta, S. M., Day, L. B., & Murthy, S. N. (2008) · Current Eye Research · doi:10.1080/02713680802270945 · Cited by 46
Functional and molecular analysis of d-serine transport in retinal Müller cells
Dun, Y., Mysona, B. A., Itagaki, S., Martin-Studdard, A., Ganapathy, V., & Smith, S. B. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.09.015 · Cited by 46
Anand, B. S., Katragadda, S., Nashed, Y. E., & Mitra, A. K. (2004) · Current Eye Research · doi:10.1080/02713680490504614 · Cited by 46
Self-citationVoigt, M., de Kozak, Y., Halhal, M., Courtois, Y., & Béhar‐Cohen, F. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00656-3 · Cited by 45
Sustained Subconjunctival Protein Delivery Using a Thermosetting Gel Delivery System
Rieke, E. R., Amaral, J., Becerra, S. P., & Lutz, R. J. (2010) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2009.0059 · Cited by 45
Effect of P-glycoprotein on the ocular disposition of a model substrate, quinidine
Duvvuri, S., Gandhi, M. D., & Mitra, A. K. (2003) · Current Eye Research · doi:10.1076/ceyr.27.6.345.18187 · Cited by 45
Self-citationVitreous Penetration of Orally Administered Famciclovir
Chong, D. Y., Johnson, M. W., Huynh, T. H., Hall, E. F., Comer, G. M., & Fish, D. N. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.02.010 · Cited by 45
Expression of ABC-Transporters in Human Corneal Tissue and the Transformed Cell Line, HCE-T
Becker, U., Ehrhardt, C., Schneider‐Daum, N., Baldes, C., Schaefer, U. F., Ruprecht, K. W., Kim, K., & Lehr, C. (2007) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.0095 · Cited by 45
Widespread expression of an exogenous gene in the eye after intravenous administration.
Zhu, C., Zhang, Y., & Pardridge, W. M. (2002) · PubMed · Cited by 44
Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix
Gilbert, J. A., Simpson, A. E., Rudnick, D. E., Geroski, D. H., Aaberg, T. M., & Edelhauser, H. F. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00151-2 · Cited by 44
Chew, E. Y., Glassman, A. R., Beck, R. W., Bressler, N. M., Fish, G. E., Ferris, F. L., & Kinyoun, J. L. (2010) · Retina · doi:10.1097/iae.0b013e3181f049a8 · Cited by 44
Penetration of moxifloxacin into the human aqueous humour after oral administration
Kampougeris, G. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.050054 · Cited by 44
Novel Nanoparticulate Gel Formulations of Steroids for the Treatment of Macular Edema
Boddu, S. H. S., Jwala, J., Vaishya, R. D., Earla, R., Karla, P. K., Pal, D., & Mitra, A. K. (2010) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2009.0074 · Cited by 42
Self-citationMethylprednisolone Delivery to the Back of the Eye using Hydrogel Iontophoresis
Eljarrat‐Binstock, E., Orucov, F., Frucht‐Pery, J., Pe’er, J., & Domb, A. J. (2008) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2007.0097 · Cited by 42
Methotrexate Delivery to the Eye Using Transscleral Hydrogel Iontophoresis
Eljarrat‐Binstock, E., Domb, A. J., Orucov, F., Frucht‐Pery, J., & Pe’er, J. (2007) · Current Eye Research · doi:10.1080/02713680701528674 · Cited by 42
Aqueous and Vitreous Penetration of Levofloxacin after Topical and/or Oral Administration
Sakamoto, H., Sakamoto, M., Hata, Y., Kubota, T., & Ishibashi, T. (2007) · European Journal of Ophthalmology · doi:10.1177/112067210701700316 · Cited by 40
Valls, R., Vega, E., García, M. L., Egea, M. A., & Vall�s, J. (2008) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104500802010066 · Cited by 40
Mishra, G. P., Tamboli, V., & Mitra, A. K. (2011) · Colloid & Polymer Science · doi:10.1007/s00396-011-2476-y · Cited by 40
Self-citationTalluri, R. S., Katragadda, S., Pal, D., & Mitra, A. K. (2006) · Current Eye Research · doi:10.1080/02713680600693629 · Cited by 40
Self-citationOcular distribution of intravenously administered micafungin in rabbits
Suzuki, T., Uno, T., Chen, G., & Ohashi, Y. (2008) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-008-0612-5 · Cited by 40
Ocular Sustained Release Nanoparticles Containing Stereoisomeric Dipeptide Prodrugs of Acyclovir
Jwala, J., Boddu, S. H. S., Shah, S. J., Sirimulla, S., Pal, D., & Mitra, A. K. (2011) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2010.0188 · Cited by 39
Self-citationFibrin-Enmeshed Tobramycin Liposomes: Single Application Topical Therapy of Pseudomonas Keratitis
Frucht-Perry, J., Assil, K. K., Ziegler, E. J., Douglas, H., Brown, S. I., Schanzlin, D. J., & Weinreb, R. N. (1992) · Cornea · doi:10.1097/00003226-199209000-00006 · Cited by 39
Does orally administered doxycycline reach the tear film?
Smith, V. A., Khan-Lim, D., Anderson, L., Cook, S. D., & Dick, A. D. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.125989 · Cited by 39
Harrison, S. C. (2010) · Science · doi:10.1126/science.1194922 · Cited by 38
Effect of Poly(amidoamine) Dendrimers on Corneal Penetration of Puerarin
Yao, W., Sun, K., Liu, Y., Liang, N., Mu, H., Yao, C., Liang, R., & Wang, A. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1371 · Cited by 38
Hughes, P. M., & Mitra, A. K. (1993) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1993.9.299 · Cited by 38
Self-citation
Cited by
Sorted by citations
Ocular drug delivery systems: An overview
Patel, A. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i2.47 · Cited by 894
Advances in Biomaterials for Drug Delivery
Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 890
Emerging Targets in Photopharmacology
Lerch, M. M., Hansen, M. J., van Dam, G. M., Szymański, W., & Feringa, B. L. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601931 · Cited by 674
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 622
An overview of clinical and commercial impact of drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.053 · Cited by 525
Metadata
- Authors
- Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K.
- Affiliations
- University of Missouri–Kansas City (US)
- Corresponding author
- Mitra, Ashim K.
- Venue
- The AAPS Journal
- Published
- 2010-05-01
- Volume
- 12
- Issue
- 3
- Pages
- 348-360
- ISSN
- 1550-7416 (ISSN-L)
- PMC
- PMC2895432
- OpenAlex
- W2018516156
- Cited by
- 1,406
- References
- 256
- Citations by year
- 2026: 114 · 2025: 114 · 2024: 98 · 2023: 118 · 2022: 110 · 2021: 126 · 2020: 116 · 2019: 93 · 2018: 100 · 2017: 96 · 2016: 82 · 2015: 60 · 2014: 54 · 2013: 58 · 2012: 32
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- The AAPS Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (R01EY009171, R01EY10659-12, R01EY010659, R01-EY09171-14)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- ocular drug delivery, blood-aqueous barrier, blood-retinal barrier, cornea, sclera, retina, choroidal blood flow, lymphatic clearance, efflux pumps, influx transporters, nanoparticles, nanomicelles, liposomes, microemulsions, bioadhesive gel, fibrin glue, sustained drug release, topical drug delivery, posterior segment, anterior segment
- MeSH terms
- Administration, Topical, Colloids, Eye, Half-Life, Humans, Iontophoresis, Melanins, Pharmacokinetics, Ultrasonics, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review